Inhibition of HIV replication by A77 1726, the active metabolite of leflunomide, in combination with pyrimidine nucleoside reverse transcriptase inhibitors.

Hossain, M M

Inhibition of HIV replication by A77 1726, the active metabolite of leflunomide, in combination with pyrimidine nucleoside reverse transcriptase inhibitors. [electronic resource] - Journal of acquired immune deficiency syndromes (1999) Oct 2001 - 199-201 p. digital

Publication Type: Letter

1525-4135

10.1097/00042560-200110010-00016 doi


Aniline Compounds--blood
Anti-HIV Agents--pharmacology
Anti-Inflammatory Agents, Non-Steroidal--pharmacology
Crotonates
HIV--drug effects
HIV Core Protein p24--biosynthesis
HIV Seronegativity
Humans
Hydroxybutyrates--blood
Immunosuppressive Agents--pharmacology
Isoxazoles--blood
Leflunomide
Lymphocytes--drug effects
Nitriles
Reverse Transcriptase Inhibitors--blood
Toluidines
Virus Replication--drug effects
Zidovudine--pharmacology